{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T06:21:59Z","timestamp":1783578119303,"version":"3.55.0"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Biomaterialia"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.actbio.2024.05.048","type":"journal-article","created":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T12:40:45Z","timestamp":1717591245000},"page":"318-329","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Next-generation nanovaccine induces durable immunity and protects against SARS-CoV-2"],"prefix":"10.1016","volume":"183","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2510-6779","authenticated-orcid":false,"given":"Kathleen A.","family":"Ross","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5833-7456","authenticated-orcid":false,"given":"Sean","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kruttika S.","family":"Phadke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5212-9541","authenticated-orcid":false,"given":"Nathan","family":"Peroutka-Bigus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3893-5234","authenticated-orcid":false,"given":"Olufemi","family":"Fasina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4123-8130","authenticated-orcid":false,"given":"Alaric","family":"Siddoway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9482-7273","authenticated-orcid":false,"given":"Surya K.","family":"Mallapragada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Wannemuehler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan H.","family":"Bellaire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7955-5353","authenticated-orcid":false,"given":"Balaji","family":"Narasimhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.actbio.2024.05.048_bib0001","unstructured":"World Health Organization, Coronavirus (COVID-19), www.who.int (2023)."},{"issue":"3","key":"10.1016\/j.actbio.2024.05.048_bib0002","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41579-020-00459-7","article-title":"Characteristics of SARS-CoV-2 and COVID-19","volume":"19","author":"Hu","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"issue":"1","key":"10.1016\/j.actbio.2024.05.048_bib0003","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41580-021-00418-x","article-title":"Mechanisms of SARS-CoV-2 entry into cells","volume":"23","author":"Jackson","year":"2022","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"issue":"2","key":"10.1016\/j.actbio.2024.05.048_bib0004","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/path.1570","article-title":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis","volume":"203","author":"Hamming","year":"2004","journal-title":"J. Pathol."},{"issue":"3","key":"10.1016\/j.actbio.2024.05.048_bib0005","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.3390\/ijms22031308","article-title":"The SARS-coronavirus infection cycle: a survey of viral membrane proteins, their functional interactions and pathogenesis","volume":"22","author":"Wong","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"7830","key":"10.1016\/j.actbio.2024.05.048_bib0006","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/s41586-020-2622-0","article-title":"SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness","volume":"586","author":"Corbett","year":"2020","journal-title":"Nature"},{"issue":"25","key":"10.1016\/j.actbio.2024.05.048_bib0007","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1056\/NEJMoa2027906","article-title":"Safety and immunogenicity of two RNA-based covid-19 vaccine candidates","volume":"383","author":"Walsh","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"32","key":"10.1016\/j.actbio.2024.05.048_bib0008","doi-asserted-by":"crossref","first-page":"4423","DOI":"10.1016\/j.vaccine.2021.05.063","article-title":"Evidence for antibody as a protective correlate for COVID-19 vaccines","volume":"39","author":"Earle","year":"2021","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.actbio.2024.05.048_bib0009","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1038\/s41591-021-01377-8","article-title":"Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection","volume":"27","author":"Khoury","year":"2021","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.actbio.2024.05.048_bib0010","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41392-022-00997-x","article-title":"SARS-CoV-2 Omicron variant: recent progress and future perspectives","volume":"7","author":"Fan","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"issue":"2","key":"10.1016\/j.actbio.2024.05.048_bib0011","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/s41590-021-01122-w","article-title":"The T cell immune response against SARS-CoV-2","volume":"23","author":"Moss","year":"2022","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.actbio.2024.05.048_bib0012","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.633184","article-title":"Antibody responses in COVID-19: a review","volume":"12","author":"Chvatal-Medina","year":"2021","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.actbio.2024.05.048_bib0013","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jconrel.2004.08.006","article-title":"Encapsulation, stabilization, and release of BSA-FITC from polyanhydride microspheres","volume":"100","author":"Determan","year":"2004","journal-title":"J. Control. Release"},{"issue":"22","key":"10.1016\/j.actbio.2024.05.048_bib0014","doi-asserted-by":"crossref","first-page":"4405","DOI":"10.1016\/S0142-9612(02)00181-3","article-title":"Design of an injectable system based on bioerodible polyanhydride microspheres for sustained drug delivery","volume":"23","author":"Kipper","year":"2002","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.actbio.2024.05.048_bib0015","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0168-3659(02)00125-6","article-title":"Mechanistic relationships between polymer microstructure and drug release kinetics in bioerodible polyanhydrides","volume":"82","author":"Shen","year":"2002","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.actbio.2024.05.048_bib0016","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/jbm.b.32820","article-title":"Single immunization with a suboptimal antigen dose encapsulated into polyanhydride microparticles promotes high titer and avid antibody responses","volume":"101","author":"Huntimer","year":"2013","journal-title":"J. Biomed. Mater. Res. B"},{"issue":"4","key":"10.1016\/j.actbio.2024.05.048_bib0017","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1002\/jbm.a.30545","article-title":"Single dose vaccine based on biodegradable polyanhydride microspheres can modulate immune response mechanism","volume":"76","author":"Kipper","year":"2006","journal-title":"J. Biomed. Mater. Res. A"},{"issue":"3","key":"10.1016\/j.actbio.2024.05.048_bib0018","doi-asserted-by":"crossref","first-page":"e17642","DOI":"10.1371\/journal.pone.0017642","article-title":"Design of a protective single-dose intranasal nanoparticle-based vaccine platform for respiratory infectious diseases","volume":"6","author":"Ulery","year":"2011","journal-title":"PLoS ONE"},{"issue":"6","key":"10.1016\/j.actbio.2024.05.048_bib0019","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1166\/jbn.2016.2242","article-title":"Polyanhydride nanovaccines induce germinal center B cell formation and sustained serum antibody responses","volume":"12","author":"Vela Ramirez","year":"2016","journal-title":"J. Biomed. Nanotechnol."},{"key":"10.1016\/j.actbio.2024.05.048_bib0020","doi-asserted-by":"crossref","first-page":"6579","DOI":"10.2147\/IJN.S261041","article-title":"Polyanhydride nanoparticles induce low inflammatory dendritic cell activation resulting in CD8(+) T cell memory and delayed tumor progression","volume":"15","author":"Darling","year":"2020","journal-title":"Int. J. Nanomed."},{"issue":"2","key":"10.1016\/j.actbio.2024.05.048_bib0021","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1142\/S2339547814500162","article-title":"Polyanhydride nanovaccine platform enhances antigen-specific cytotoxic T cell responses","volume":"2","author":"Huntimer","year":"2014","journal-title":"Technology"},{"issue":"3","key":"10.1016\/j.actbio.2024.05.048_bib0022","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1039\/C8BM01443D","article-title":"Single dose combination nanovaccine provides protection against influenza A virus in young and aged mice","volume":"7","author":"Ross","year":"2019","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.actbio.2024.05.048_bib0023","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.3389\/fimmu.2018.01953","article-title":"Polyanhydride nanovaccine induces robust pulmonary B and T cell immunity and confers protection against homologous and heterologous influenza A virus infections","volume":"9","author":"Zacharias","year":"2018","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.actbio.2024.05.048_bib0024","doi-asserted-by":"crossref","first-page":"15157","DOI":"10.1038\/s41598-019-51684-x","article-title":"Vitamin A deficiency impairs the immune response to intranasal vaccination and RSV infection in neonatal calves","volume":"9","author":"McGill","year":"2019","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.actbio.2024.05.048_bib0025","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1038\/s41598-018-21292-2","article-title":"Efficacy of mucosal polyanhydride nanovaccine against respiratory syncytial virus infection in the neonatal calf","volume":"8","author":"McGill","year":"2018","journal-title":"Sci. Rep."},{"issue":"1 Supplement","key":"10.1016\/j.actbio.2024.05.048_bib0026","doi-asserted-by":"crossref","first-page":"166.3","DOI":"10.4049\/jimmunol.204.Supp.166.3","article-title":"Polyanhydride-based RSV prefusion F nanoparticle vaccine establishes lasting protection mediated by humoral and cellular immune responses","volume":"204","author":"Stephens","year":"2020","journal-title":"J. Immunol."},{"key":"10.1016\/j.actbio.2024.05.048_bib0027","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.actbio.2019.10.016","article-title":"Single-dose combination nanovaccine induces both rapid and long-lived protection against pneumonic plague","volume":"100","author":"Wagner","year":"2019","journal-title":"Acta Biomater."},{"key":"10.1016\/j.actbio.2024.05.048_bib0028","doi-asserted-by":"crossref","first-page":"325","DOI":"10.3389\/fimmu.2018.00325","article-title":"Room temperature stable PspA-based nanovaccine induces protective immunity","volume":"9","author":"Wagner-Muniz","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.actbio.2024.05.048_bib0029","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.actbio.2014.11.050","article-title":"Effective polymer adjuvants for sustained delivery of protein subunit vaccines","volume":"14","author":"Adams","year":"2015","journal-title":"Acta Biomater."},{"issue":"32","key":"10.1016\/j.actbio.2024.05.048_bib0030","doi-asserted-by":"crossref","first-page":"eabj1691","DOI":"10.1126\/sciadv.abj1691","article-title":"Self-assembling synthetic nanoadjuvant scaffolds cross-link B cell receptors and represent new platform technology for therapeutic antibody production","volume":"7","author":"Senapati","year":"2021","journal-title":"Sci. Adv."},{"issue":"3","key":"10.1016\/j.actbio.2024.05.048_bib0031","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1021\/acsbiomaterials.8b01591","article-title":"Pentablock copolymer micelle nanoadjuvants enhance cytosolic delivery of antigen and improve vaccine efficacy while inducing low inflammation","volume":"5","author":"Senapati","year":"2019","journal-title":"ACS Biomater. Sci. Eng."},{"issue":"3","key":"10.1016\/j.actbio.2024.05.048_bib0032","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1021\/acsbiomaterials.5b00477","article-title":"Combination nanovaccine demonstrates synergistic enhancement in efficacy against influenza","volume":"2","author":"Ross","year":"2016","journal-title":"ACS Biomater. Sci. Eng."},{"issue":"2","key":"10.1016\/j.actbio.2024.05.048_bib0033","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.chom.2016.01.010","article-title":"The cGAS-STING defense pathway and its counteraction by viruses","volume":"19","author":"Ma","year":"2016","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.actbio.2024.05.048_bib0034","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.actbio.2017.01.005","article-title":"The effect of polyanhydride chemistry in particle-based cancer vaccines on the magnitude of the anti-tumor immune response","volume":"50","author":"Wafa","year":"2017","journal-title":"Acta Biomater."},{"key":"10.1016\/j.actbio.2024.05.048_bib0035","first-page":"95","article-title":"Poly[1,3-bis(p-carboxyphenoxy)-propane anhydride]","volume":"2","author":"Conix","year":"1966","journal-title":"Macro. Synth."},{"issue":"1","key":"10.1016\/j.actbio.2024.05.048_bib0036","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/jbm.a.30510","article-title":"Synthesis and characterization of novel polyanhydrides with tailored erosion mechanisms","volume":"76","author":"Torres","year":"2006","journal-title":"J. Biomed. Mater. Res. A"},{"issue":"10","key":"10.1016\/j.actbio.2024.05.048_bib0037","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines11101572","article-title":"Synthesis and optimization of next-generation low-molecular-weight pentablock copolymer nanoadjuvants","volume":"11","author":"Siddoway","year":"2023","journal-title":"Vaccines"},{"issue":"12","key":"10.1016\/j.actbio.2024.05.048_bib0038","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1002\/macp.201300034","article-title":"Novel atom transfer radical polymerization method to yield copper-free block copolymeric biomaterials","volume":"214","author":"Adams","year":"2013","journal-title":"Macromol. Chem. Phys."},{"issue":"18","key":"10.1016\/j.actbio.2024.05.048_bib0039","doi-asserted-by":"crossref","first-page":"6933","DOI":"10.1016\/j.polymer.2005.05.138","article-title":"Synthesis and characterization of temperature and pH-responsive pentablock copolymers","volume":"46","author":"Determan","year":"2005","journal-title":"Polymer"},{"issue":"6","key":"10.1016\/j.actbio.2024.05.048_bib0040","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1172\/JCI79915","article-title":"Nanoparticulate STING agonists are potent lymph node\u2013targeted vaccine adjuvants","volume":"125","author":"Hanson","year":"2015","journal-title":"J. Clin. Invest."},{"issue":"7085","key":"10.1016\/j.actbio.2024.05.048_bib0041","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1038\/nature04596","article-title":"Toll-dependent selection of microbial antigens for presentation by dendritic cells","volume":"440","author":"Blander","year":"2006","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.actbio.2024.05.048_bib0042","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1038\/s41423-021-00743-3","article-title":"SARS-CoV-2-specific T cells in infection and vaccination","volume":"18","author":"Bertoletti","year":"2021","journal-title":"Cell. Mol. Immunol."},{"issue":"1","key":"10.1016\/j.actbio.2024.05.048_bib0043","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3390\/vaccines11010101","article-title":"Updated insights into the T cell-mediated immune response against SARS-CoV-2: a step towards efficient and reliable vaccines","volume":"11","author":"Dhawan","year":"2023","journal-title":"Vaccines"},{"issue":"11","key":"10.1016\/j.actbio.2024.05.048_bib0044","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1038\/s41590-020-0778-2","article-title":"SARS-CoV-2 infection of human ACE2-transgenic mice causes severe lung inflammation and impaired function","volume":"21","author":"Winkler","year":"2020","journal-title":"Nat. Immunol."},{"issue":"6561","key":"10.1016\/j.actbio.2024.05.048_bib0045","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1126\/science.abj4176","article-title":"Durability of mRNA-1273 vaccine-induced antibodies against SARS-CoV-2 variants","volume":"373","author":"Pegu","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.actbio.2024.05.048_bib0046","first-page":"2213","article-title":"Combinatorial evaluation of in vivo distribution of polyanhydride particle-based platforms for vaccine delivery","volume":"8","author":"Petersen","year":"2013","journal-title":"Int. J. Nanomed."},{"issue":"3","key":"10.1016\/j.actbio.2024.05.048_bib0047","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/s41423-022-00838-5","article-title":"T cell epitopes in SARS-CoV-2 proteins are substantially conserved in the Omicron variant","volume":"19","author":"Choi","year":"2022","journal-title":"Cell. Mol. Immunol."},{"issue":"11","key":"10.1016\/j.actbio.2024.05.048_bib0048","doi-asserted-by":"crossref","DOI":"10.1084\/jem.2020218710052021c","article-title":"Correction: mapping and role of T cell response in SARS-CoV-2\u2013infected mice","volume":"218","author":"Zhuang","year":"2021","journal-title":"J. Exp. Med."},{"issue":"2","key":"10.1016\/j.actbio.2024.05.048_bib0049","doi-asserted-by":"crossref","first-page":"381","DOI":"10.3201\/eid2902.221422","article-title":"Correlates of protection, thresholds of protection, and immunobridging among persons with SARS-CoV-2 infection","volume":"29","author":"Khoury","year":"2023","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.actbio.2024.05.048_bib0050","doi-asserted-by":"crossref","unstructured":"S. Mink, W. List, G. Hoefle, M. Frick, A. Suessenbacher, T. Winder, C. Fetz, A. Boesl, C.H. Saely, H. Drexel, P. Fraunberger, Evaluation of SARS-CoV-2 antibody levels on hospital admission as a correlate of protection against mortality, J. Intern. Med. 293(6) 694\u2013703.","DOI":"10.1111\/joim.13606"},{"issue":"7898","key":"10.1016\/j.actbio.2024.05.048_bib0051","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/s41586-021-04388-0","article-title":"Striking antibody evasion manifested by the Omicron variant of SARS-CoV-2","volume":"602","author":"Liu","year":"2022","journal-title":"Nature"},{"issue":"61","key":"10.1016\/j.actbio.2024.05.048_bib0052","doi-asserted-by":"crossref","first-page":"eabg5669","DOI":"10.1126\/sciimmunol.abg5669","article-title":"CD8+ T cells specific for conserved coronavirus epitopes correlate with milder disease in patients with COVID-19","volume":"6","author":"Mallajosyula","year":"2021","journal-title":"Sci. Immunol."},{"issue":"7901","key":"10.1016\/j.actbio.2024.05.048_bib0053","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/s41586-022-04465-y","article-title":"Vaccines elicit highly conserved cellular immunity to SARS-CoV-2 Omicron","volume":"603","author":"Liu","year":"2022","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.actbio.2024.05.048_bib0054","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.cell.2022.01.015","article-title":"SARS-CoV-2 vaccination induces immunological T cell memory able to cross-recognize variants from Alpha to Omicron","volume":"185","author":"Tarke","year":"2022","journal-title":"Cell"},{"issue":"17","key":"10.1016\/j.actbio.2024.05.048_bib0055","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1016\/j.vaccine.2016.02.063","article-title":"Memory T cell responses targeting the SARS coronavirus persist up to 11 years post-infection","volume":"34","author":"Ng","year":"2016","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.actbio.2024.05.048_bib0056","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.cell.2022.02.005","article-title":"Respiratory mucosal delivery of next-generation COVID-19 vaccine provides robust protection against both ancestral and variant strains of SARS-CoV-2","volume":"185","author":"Afkhami","year":"2022","journal-title":"Cell"}],"container-title":["Acta Biomaterialia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706124003003?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706124003003?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T11:59:25Z","timestamp":1720612765000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1742706124003003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":56,"alternative-id":["S1742706124003003"],"URL":"https:\/\/doi.org\/10.1016\/j.actbio.2024.05.048","relation":{},"ISSN":["1742-7061"],"issn-type":[{"value":"1742-7061","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Next-generation nanovaccine induces durable immunity and protects against SARS-CoV-2","name":"articletitle","label":"Article Title"},{"value":"Acta Biomaterialia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.actbio.2024.05.048","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Ltd on behalf of Acta Materialia Inc.","name":"copyright","label":"Copyright"}]}}